TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2025

The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLC.

Jhanelle E Gray et al.PubMed ↗Publisher ↗

No numbers read from the abstract.